OncBioMune, AqVida add additional drugs to distribution agreement (Paclitaxel and Oxaliplatin)
BATON ROUGE, LA--(Marketwired - June 15, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a …